1,25-Dihydroxyvitamin D(3) increases striatal GDNF mRNA and protein expression in adult rats.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Brain Research. Molecular Brain Research

• Publication date

  2002-12-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0169-328X(02)00545-4PMID 12480187
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pit-1/GHF-1 and GH expression in the MCF-7 human breast adenocarcinoma cell line.

  2002cited by this paper
• Protective effects of 1α,25-(OH)2D3 against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture

  2001cited by this paper
• Protective effects of 1 alpha,25-(OH)(2)D(3) against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture.

  2001cited by this paper
• Neurotrophic factors in Alzheimer's and Parkinson's disease brain.

  2000cited by this paper
• Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6‐OHDA lesion model depends on the site of administration of the trophic factor

  2000cited by this paper
• Vitamin D(3) attenuates cortical infarction induced by middle cerebral arterial ligation in rats.

  2000cited by this paper
• Mechanisms of gene regulation by vitamin D(3) receptor: a network of coactivator interactions.

  2000cited by this paper
• Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord.

  1999cited by this paper
• Striatal dopaminergic afferents concentrate in GDNF‐positive patches during development and in developing intrastriatal striatal grafts

  1999cited by this paper
• The role of neuronal growth factors in neurodegenerative disorders of the human brain.

  1998cited by this paper
• 1,25-Dihydroxyvitamin D3 receptors in the central nervous system of the rat embryo.

  1998cited by this paper
• Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease.

  1997cited by this paper
• 1,25‐Dihydroxyvitamin D3, an inducer of glial cell line‐derived neurotrophic factor

  1996cited by this paper
• 1,25 Dihydroxyvitamin D3 Exerts Regional Effects in the Central Nervous System during Experimental Allergic Encephalomyelitis

  1996cited by this paper
• Functional recovery in parkinsonian monkeys treated with GDNF

  1996cited by this paper
• Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo

  1995cited by this paper
• GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons.

  1993cited by this paper
• 1,25‐Dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis

  1991cited by this paper
• Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid.

  1979cited by this paper

• The Role of Vitamin D in Parkinson's Disease

  2025cites this paper
• The Role of Vitamin D in Parkinson’s Disease: Evidence from Serum Concentrations, Supplementation, and VDR Gene Polymorphisms

  2025cites this paper
• Vitamin D3 improves iminodipropionitrile-induced tic-like behavior in rats through regulation of GDNF/c-Ret signaling activity

  2024cites this paper
• Role of Calcitriol and Vitamin D Receptor (VDR) Gene Polymorphisms in Alzheimer’s Disease

  2024cites this paper
• Molecular Regulation of the CNS by Vitamin D.

  2023cites this paper
• Understanding the Molecular Aspects of Vitamins in Parkinson's Disease: Present-day Concepts and Perspectives.

  2023cites this paper
• Nonaqueous Capillary Electrophoretic Separation of Analogs of (24R)-1,24-Dihydroxyvitamin D3 Derivative as Predicted by Quantum Chemical Calculations

  2023cites this paper
• Calcitriol protects against reductions in striatal serotonin in rats treated with neurotoxic doses of methamphetamine.

  2023cites this paper
• Vitamin D Status and Parkinson’s Disease

  2022cites this paper
• Vitamin D

  2022cites this paper
• The effect of vitamin D supplementation on tobacco-related disorders in individuals with a tobacco use disorder: a randomized clinical trial

  2021cites this paper
• Vitamin-D

  2020cites this paper
• The Effects of Vitamin D Deficiency on Neurodegenerative Diseases

  2019cites this paper
• Benefits of Vitamins in the Treatment of Parkinson's Disease

  2019cites this paper
• Vitamin D Deficiency in Middle Childhood Is Related to Behavior Problems in Adolescence.

  2019cites this paper
• Chapter 15 – Parkinson’s Disease

  2018cites this paper
• Vitamin D in neurological and neurodegenerative patients: Current knowledge and future perspectives

  2018cites this paper
• Reduced ability of calcitriol to promote augmented dopamine release in the lesioned striatum of aged rats

  2017influential citation
• Vitamin D regulation of GDNF/Ret signaling in dopaminergic neurons

  2017cites this paper
• Is there a role for vitamin D in supporting cognitive function as we age?

  2017cites this paper
• Vitamin D and the brain: Genomic and non-genomic actions.

  2017cites this paper
• Alpha-synuclein, epigenetics, mitochondria, metabolism, calcium traffic, & circadian dysfunction in Parkinson's disease. An integrated strategy for management.

  2017cites this paper
• Vitamin D

  2016cites this paper
• The Role of Vitamin D₃ in the Development and Neuroprotection of Midbrain Dopamine Neurons.

  2016cites this paper
• Vitamin D deficiency in Parkinson's disease patients with orthostatic hypotension

  2015cites this paper
• Vitamin D regulates tyrosine hydroxylase expression: N-cadherin a possible mediator.

  2015cites this paper
• Rôles bénéfiques de la vitamine D sur la neurodégénérescence et les troubles mentaux

  2014cites this paper
• Vitamin D as a Potential Therapy in Amyotrophic Lateral Sclerosis

  2014cites this paper
• Calcitriol Promotes Augmented Dopamine Release in the Lesioned Striatum of 6-Hydroxydopamine Treated Rats

  2014cites this paper
• [Role of vitamin D in the physiopathology of neurodegenerative diseases].

  2014cites this paper
• Beneficial effects of vitamin D on neurodegeneration and mental diseases

  2014cites this paper
• Role de la vitamine D dans la physiopathologie des maladies neurodegeneratives

  2014cites this paper
• Vitamin D as a neurosteroid affecting the developing and adult brain.

  2014cites this paper
• The relationship between balance control and vitamin D in Parkinson's disease—a pilot study

  2013cites this paper
• Vitamin D: preventive and therapeutic potential in Parkinson's disease.

  2013cites this paper
• Calcitriol Imparts Neuroprotection In Vitro to Midbrain Dopaminergic Neurons by Upregulating GDNF Expression

  2013cites this paper
• The Relationship Basal Ganglia Calcification and Level Of 25 ( OH )-D and Parathyroid Hormone in Patients With Parkinson ' s Disease

  2013influential citation
• Vitamin D as an effective treatment approach for drug abuse and addiction

  2013cites this paper
• Vitamin D3 at 50x AI Attenuates the Decline in Paw Grip Endurance, but Not Disease Outcomes, in the G93A Mouse Model of ALS, and Is Toxic in Females

  2013cites this paper
• Dietary Vitamin D3 Supplementation at 10× the Adequate Intake Improves Functional Capacity in the G93A Transgenic Mouse Model of ALS, a Pilot Study

  2012cites this paper
• Evoked dopamine overflow is augmented in the striatum of calcitriol treated rats.

  2012influential citation
• Vitamin D und Multiple Sklerose

  2012cites this paper
• Glial cell line-derived neurotrophic factor effects on dental pulp cells and osteoblast-like cells

  2012cites this paper
• Vitamin D: Defending the Aging Nervous System

  2012cites this paper
• Role of Vitamin D in Parkinson's Disease

  2012cites this paper
• Vitamin D deficiency reduces the benefits of progesterone treatment after brain injury in aged rats.

  2011cites this paper
• Imipramine activates glial cell line-derived neurotrophic factor via early growth response gene 1 in astrocytes.

  2011cites this paper
• Generación de neuronas dopaminérgicas a partir de células madre neurales mesencefálicas : nuevas contribuciones al desarrollo de terapia celular para la enfermedad de Parkinson

  2011cites this paper
• Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases.

  2009influential citation
• Progesterone with Vitamin D Affords Better Neuroprotection against Excitotoxicity in Cultured Cortical Neurons than Progesterone Alone

  2009cites this paper
• 1,25‐Dihydroxyvitamin D3 administration to 6‐hydroxydopamine‐lesioned rats increases glial cell line‐derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum

  2009cites this paper
• GDNF--a potential target to treat addiction.

  2009cites this paper
• Vitamin‐regulated cytokines and growth factors in the CNS and elsewhere

  2009cites this paper
• Transient prenatal vitamin D deficiency is associated with changes of synaptic plasticity in the dentate gyrus in adult rats.

  2009cites this paper
• Neuroprotection by co-treatment and post-treating with calcitriol following the ischemic and excitotoxic insult in vivo and in vitro.

  2009cites this paper
• Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction?

  2008influential citation
• GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR MODULATES STRUCTURE AND FUNCTION OF POSTNATAL MYENTERIC NEURONS

  2008cites this paper
• CHAPTER 64 – Vitamin D

  2008cites this paper
• Driving GDNF expression: the green and the red traffic lights.

  2008cites this paper
• Etude des effets des radionucléides (uranium et césium 137) sur le métabolisme de la vitamine D chez le rat

  2007influential citation
• Vitamin D and Parkinson's disease—A hypothesis

  2007cites this paper
• Down-regulation of microglial activation may represent a practical strategy for combating neurodegenerative disorders.

  2006cites this paper
• 1α,25-Dihydroxyvitamin D3 Protects Dopaminergic Neurons in Rodent Models of Parkinson's Disease through Inhibition of Microglial Activation

  2006cites this paper
• Calcitriol Protects against the Dopamine‐ and Serotonin‐Depleting Effects of Neurotoxic Doses of Methamphetamine

  2006cites this paper
• Calcitriol Protection against Dopamine Loss Induced by Intracerebroventricular Administration of 6-Hydroxydopamine

  2006cites this paper
• The Effect of 1,25-Dihydroxyvitamin D3 on Dopaminergic Neurons and Microglial Activation in Parkinsonian Rat Model Induced by 6-Hydroxydopamine

  2005cites this paper
• Low power laser irradiation alters gene expression of olfactory ensheathing cells in vitro

  2005cites this paper
• Association of Vitamin D Receptor Gene Polymorphism and Parkinson's Disease in Koreans

  2005cites this paper
• Effects of 1alpha,25 dihydroxyvitamin D3 on the expression of HO-1 and GFAP in glial cells of the photothrombotically lesioned cerebral cortex.

  2004cites this paper
• Mechanisms of Neuroprotective Action of Vitamin D3

  2004cites this paper
• Schizophrenia, vitamin D, and brain development.

  2004cites this paper